Dexrazoxane mitigates long-term cardiotoxicities of doxorubicin for young patients
In an interview with Healio, Erin Mobley, Ph.D., discussed her study on the cardioprotective effects of dexrazoxane in pediatric cancer survivors.
In an interview with Healio, Erin Mobley, Ph.D., discussed her study on the cardioprotective effects of dexrazoxane in pediatric cancer survivors.
The event showcased aimed to ensure the cancer patient of today does not become the cardiac patient of tomorrow.
Research from the Cardio-Oncology Symposium has been published in the American Heart Journal Plus: Cardiology Research and Practice.
The UF Cardio-Oncology Symposium on March 1 brought together UF faculty, staff and students to foster new collaborations.